Answers are grounded in this paper and cite their sources.
Background Osteoarthritis (OA) lacks effective therapies to halt progression. This study developed Bai@Cu-MOF, a baicalin-loaded copper-based metal–organic framework nanocomposite, evaluating its properties and anti-OA efficacy.Method Bai@Cu-MOF displayed uniform polyhedral morphology, positive surface charge, and excellent stability and hemocompatibility. In vitro, it was efficiently uptake by chondrocytes without significant cytotoxicity and exhibited potent superoxide anion scavenging. In IL-1β-induced inflammatory chondrocytes, Bai@Cu-MOF upregulated anabolic markers (Aggrecan, Col2a1, Sox9) while downregulating catabolic enzymes (MMP-13, ADAMTS-5, MMP-3, COX-2). It further reduced pro-inflammatory cytokines (IL-1β, TNF-α, IL-6), enhanced antioxidant capacity by decreasing ROS, O2-•, •OH, and MDA while increasing SOD activity, and suppressed apoptosis. In a murine OA model, intra-articular Bai@Cu-MOF injection achieved joint-targeted retention, significantly alleviating cartilage destruction.Result Immunohistochemistry and Western blot confirmed increased Aggrecan and Col2a1 expression alongside inhibited MMP-13 and ADAMTS-5 in vivo, concurrently attenuating inflammation and oxidative stress.Conclusion Collectively, Bai@Cu-MOF exerts robust chondroprotective effects via combined anti-inflammatory, antioxidant, and anti-apoptotic mechanisms, demonstrating great potential as a targeted nanotherapeutic platform for cartilage protection.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: